
AbbVie Bets on Durham: $1.4B Manufacturing Campus to Create 734 Jobs
AbbVie announced a $1.4 billion investment to build a 185-acre pharmaceutical manufacturing campus in Durham, North Carolina, near Research Triangle Park, integrating advanced, AI-enabled manufacturing to support its immunology, neuroscience and oncology medicines. Construction starts in 2026 and is expected to finish by the end of 2028, creating about 734 jobs in manufacturing and laboratory roles, while generating more than 2,000 construction jobs during development. The project represents AbbVie’s largest U.S. capital investment to date and its first major manufacturing footprint in North Carolina, supported by the region’s skilled workforce.











